Kim van Zoonen1, Claudia Buntrock, David Daniel Ebert, Filip Smit, Charles F Reynolds, Aartjan T F Beekman, Pim Cuijpers. 1. Department of Clinical Psychology and EMGO Institute for Health and Care Research, VU University, Amsterdam, The Netherlands, Leuphana University Innovation Incubator, Division Health Trainings Online, Lüneburg, Germany, Philips University, Department of Psychology, Clinical Psychology and Psychotherapy, Marburg, Germany, Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Utrecht, The Netherlands, Department of Epidemiology and Biostastics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA and Department of Psychiatry and EMGO Institute for Health and Care Research, VU University, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Depressive disorders are highly prevalent, have a detrimental impact on the quality of life of patients and their relatives and are associated with increased mortality rates, high levels of service use and substantial economic costs. Current treatments are estimated to only reduce about one-third of the disease burden of depressive disorders. Prevention may be an alternative strategy to further reduce the disease burden of depression. METHODS: We conducted a meta-analysis of randomized controlled trials examining the effects of preventive interventions in participants with no diagnosed depression at baseline on the incidence of diagnosed depressive disorders at follow-up. We identified 32 studies that met our inclusion criteria. RESULTS: We found that the relative risk of developing a depressive disorder was incidence rate ratio = 0.79 (95% confidence interval: 0.69-0.91), indicating a 21% decrease in incidence in prevention groups in comparison with control groups. Heterogeneity was low (I(2) = 24%). The number needed to treat (NNT) to prevent one new case of depressive disorder was 20. Sensitivity analyses revealed no differences between type of prevention (e.g. selective, indicated or universal) nor between type of intervention (e.g. cognitive behavioural therapy, interpersonal psychotherapy or other). However, data on NNT did show differences. CONCLUSIONS: Prevention of depression seems feasible and may, in addition to treatment, be an effective way to delay or prevent the onset of depressive disorders. Preventing or delaying these disorders may contribute to the further reduction of the disease burden and the economic costs associated with depressive disorders.
BACKGROUND:Depressive disorders are highly prevalent, have a detrimental impact on the quality of life of patients and their relatives and are associated with increased mortality rates, high levels of service use and substantial economic costs. Current treatments are estimated to only reduce about one-third of the disease burden of depressive disorders. Prevention may be an alternative strategy to further reduce the disease burden of depression. METHODS: We conducted a meta-analysis of randomized controlled trials examining the effects of preventive interventions in participants with no diagnosed depression at baseline on the incidence of diagnosed depressive disorders at follow-up. We identified 32 studies that met our inclusion criteria. RESULTS: We found that the relative risk of developing a depressive disorder was incidence rate ratio = 0.79 (95% confidence interval: 0.69-0.91), indicating a 21% decrease in incidence in prevention groups in comparison with control groups. Heterogeneity was low (I(2) = 24%). The number needed to treat (NNT) to prevent one new case of depressive disorder was 20. Sensitivity analyses revealed no differences between type of prevention (e.g. selective, indicated or universal) nor between type of intervention (e.g. cognitive behavioural therapy, interpersonal psychotherapy or other). However, data on NNT did show differences. CONCLUSIONS: Prevention of depression seems feasible and may, in addition to treatment, be an effective way to delay or prevent the onset of depressive disorders. Preventing or delaying these disorders may contribute to the further reduction of the disease burden and the economic costs associated with depressive disorders.
Authors: G N Clarke; W Hawkins; M Murphy; L B Sheeber; P M Lewinsohn; J R Seeley Journal: J Am Acad Child Adolesc Psychiatry Date: 1995-03 Impact factor: 8.829
Authors: R F Muñoz; Y W Ying; G Bernal; E J Pérez-Stable; J L Sorensen; W A Hargreaves; J Miranda; L S Miller Journal: Am J Community Psychol Date: 1995-04
Authors: Su-Chin Serene Olin; Mary McCord; Ruth E K Stein; Bonnie D Kerker; Dara Weiss; Kimberly E Hoagwood; Sarah M Horwitz Journal: J Womens Health (Larchmt) Date: 2017-04-14 Impact factor: 2.681
Authors: Philip Cheng; David A Kalmbach; Gabriel Tallent; Christine Lm Joseph; Colin A Espie; Christopher L Drake Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: Y Y Lee; J J Barendregt; E A Stockings; A J Ferrari; H A Whiteford; G A Patton; C Mihalopoulos Journal: Epidemiol Psychiatr Sci Date: 2016-08-11 Impact factor: 6.892
Authors: Mariska Bot; Ingeborg A Brouwer; Miquel Roca; Elisabeth Kohls; Brenda W J H Penninx; Ed Watkins; Gerard van Grootheest; Mieke Cabout; Ulrich Hegerl; Margalida Gili; Matthew Owens; Marjolein Visser Journal: JAMA Date: 2019-03-05 Impact factor: 56.272